期刊文献+

亚慢性镉染毒大鼠MALAT1异常表达与肝肾损伤的关系 被引量:3

Relationship of abnormal expression of MALAT1 in rats subchronic exposure to cadmium with the damage of liver and kidney
原文传递
导出
摘要 目的研究肺癌转移相关转录子1(MALAT1)在亚慢性氯化镉(Cd Cl2)染毒大鼠模型肝肾组织中的表达情况,探讨MALAT1与镉致肝肾损伤过程中的关系。方法在已建立的亚慢性Cd Cl2染毒大鼠模型中,采用实时荧光定量反转录PCR(QRT-PCR)技术检测肝肾组织中MALAT1表达情况,分析MALAT1与测定的肝功能生化指标(ALT、AST)、肾功能生化指标(BUN、SCR)、相关基因(FOXC2、BCL-2、BAX、TGF、STAT、EGFR)及肝肾镉含量的相关性。结果与各自的对照组相比,大鼠肝肾组织中MALAT1表达水平均呈不同程度的升高,并有随染毒剂量的增高而升高的趋势,高剂量组表达量分别为(2.63±1.31)和(2.73±0.99),均为对照组的2.46倍,差异均有统计学意义(均P<0.05)。肝脏组织中MALAT1表达与血清中ALT含量存在相关性(r=0.459,P<0.05);肾脏组织中MALAT1表达与肾镉(r=0.427),BUN(r=0.531),SCR(r=0.400)含量及EGFR表达水平(r=0.466)均存在相关关系(均P<0.05)。结论 MALAT1在亚慢性镉染毒大鼠肝肾组织中表达水平增高,且与肝肾功能指标含量存在相关关系。肺癌转移相关转录子1可能在镉致肝肾损伤过程中发挥作用。 [Objective]To research the expression of MALA T1 in liver and kidney tissues of rats Subchronic exposure to cadmium chloride (CdC12), investigate the relationship of MALAT1 with the damage of liver and kidney by cadmium.[nethods]In the established rats subchronic exposure to CdC12 model, real-time fluorescent quantitative reverse transcriptase polymerase chain reaction (QRT-PCR) were used to detect the expression of MALA T1 in liver and kidney tissues, and the correlation of MALA T1 with biochemical indicators of liver function(ALT, AST), biochemical indicators of kidney function (BUN, SCR), related gene (FOXC2, BCL-2, BAX, TGF, STA T and EGFR) and cadmium content in liver and kidney was analyzed.[Results]Compared with the control group, the expression level of MALAT1 in liver and kidney tissues of rats increased, and had a increasing trend with the increasing of exposure doses. The expression quantity in high-dose group were (2.63 ±1.31) and (2.73± 0.99) respectively, all increased 2.46 times compared with the control group, and the difference was statistically significant (P〈0.05). The expression of MALA T! in liver and ALT in serum were correlation (r=0.459, P〈0.05); the expression of MALA T1 in kidney and content of kidney cadmium (r=0.427), BUN (r=0.531 ), SCR (r=0.400)and EGFR (r=0.466) showed correlation (all P〈0.05 ). [Conclusion]The expression level of MALAT1 in liver and kidney tissues of rats subchronic exposure to cadmium increased, and has correlativity with the content of liver and kidney function indicators. MALAT1 may play a role in the process of cadmiuminduced liver and kidney damaged.
出处 《职业与健康》 CAS 2015年第10期1321-1324,共4页 Occupation and Health
基金 国家自然科学基金项目(项目编号:81202236 项目编号:81373038 项目编号:81072322 项目编号:81473001) 广东省科技计划项目(项目编号:2013B021800095 项目编号:2013B021800093)
关键词 氯化镉 MALAT1 亚慢性染毒 Cadmium chloride(CdC12) MALATI Subchronic exposure
  • 相关文献

参考文献14

  • 1Koyu A, Gokcimen A, Ozguner F, et al. Evaluation of the effects of cadmium on rat liver[J]. Mol Cell Biochem, 2006, 2(284) : 81-85.
  • 2Sch~pfer J, Drasch G, Schrauzer GN. Selenium and cadmium levels and ratios in prostates, livers, and kidneys of nonsmokers and smokers [J ]. Biol Trace Elem Res, 2010, 134(2) : 180-187.
  • 3Ji P, Diederichs S, Wang W, et al. MALAT-1 ,a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early- stage non-small cell lung cancer [J ] .Oncogene, 2003, 22 (39) : 8031 - 8041.
  • 4Hutchinson JN, Ensminger AW, Clemson CM, et al. A screen for nu- clear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains[J]. BMC Genomics, 2007, 8(39):1-16.
  • 5Lin R, Maeda S, Liu C, et al. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of huaman carcino- mas [ J ].Oncogene, 2007, 26 (6) : 851-858.
  • 6Lu Q, Lei YX, He CC, et al. Blood translation elongation factor- ldelta is a novel marker for cadmium exposure [J]. Int J Mol Sci, 2013, 14(3) : 5182-5197.
  • 7Ren S, Liu Y, Xu W, et al. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer [J ]. J Urol, 2013, 190(6) :2278-2287.
  • 8Kryger R,Fan L, Wilce PA, et al. MALAT-1, a non protein-coding RNA is upregulated in the cerebellum,hippocampus and brain stem of human alcoholics[J]. Alcohology, 2012,46(7) :629-634.
  • 9Schmidt LH, Spieker T, Koschmieder S, et al. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth [J]. J Thorac Oncol, 2011, 6(12) : 1984-1992.
  • 10Lai MC,Yang Z, Zhou L,et al. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplan tation[J].Med Oncol, 2012, 29(3) : 1810-1816.

二级参考文献17

  • 1徐平,陈国强,顾坚忠,施恩.六个品系清洁级大鼠和小鼠的生长、繁育和脏器重量系数[J].上海实验动物科学,1994,14(3):163-169. 被引量:31
  • 2Nojima M, Maruyama R, Yasui H, et al. Genomic screening for genes silenced by DNA methylation revealed an association between RASD1 inactivation and dexamethasone resistance in multiple myeloma [J]. Clin Cancer Res, 2009, 15 (13): 4356-4364.
  • 3Kim M J, Park BJ, Kang YS, et d. Downregulation of FUSE-binding protein and c-myc by tRNA synthetase eofactor p38 is required for lung cell differentiation [J]. Nat Genet, 2003, 34 (3): 330- 336.
  • 4Pezzi N, Prieto I, Kremer L, et ol. STAG3, a novel gene encoding a protein involved in meiotic chromosome pairing and location of STAG3-related genes flanking the Williams-Beuren syndrome deletion [J]. FASEB J, 2000, 14 (3): 581-592.
  • 5Kim JY, Kang YS, Lee JW, et al. p38 is essential for the assembly and stability of macromolecular tRNA synthetase complex: implications for its physiological significance [J]. Proc Natl Acad Sci USA, 2002, 99 (12): 7912-7916.
  • 6Kim S, Park BJ. Method for treating cancer using p38/JTV-1 and method for screening pharmaceutical composition for treating cancer [P]. US: 7196068,2003.
  • 7Chun-Guang W, Jun-Qing Y, Bei-Zhong L, et al. Anti-tumor activity of emodin against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo [J]. Eur J Pharmacol, 2010, 627 (1-3): 33-41.
  • 8Del Poeta G, Bruno A, Del Principe MI, et al. Deregulation of the mitochondrial apoptotic machinery and development of molecu- lar targeted drugs in acute myeloid leukemia [J]. Curr Cancer Drug Targets, 2008, 8 (3): 207-222.
  • 9Rahmani M, Reese E, Dai Y, et al. Cotreatment with suberanoylanilide hydroxamic acid and 17-allylamino 17-demethoxygel-danamycin synergistically induces apoptosis in Bcr-Ahl + Cells sensitive and resistant to STI571 (imatinib mesylate) in association with down-regulation of Bcr-Abl, abrogation of signal transducer and activator of transcription 5 activity, and Bax conformational change [J]. Mol Pharmacol, 2005, 67 (4): 1166-1176.
  • 10Huang XF, Luo SK, Xu J, et ol. Aurora kinase inhibitory VX- 680 increases Bax/Bcl-2 ratio and induces apoptosis in Aurora- A-high acute myeloid leukemia [J]. Blood, 2008, 111 (5): 2854-2865.

共引文献37

同被引文献41

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部